PQNT1.050%
as of Jul 21
GALD
GrowthGALDERMA GROUP AG /CHF/
Close · 3M
+3.11%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
PQNT · Weight increase · 2d
The weight for GALDERMA GROUP AG within PQNT registered a two-day consecutive increase, moving from 1.00% on July 17th to 1.05% by July 19th. This specific, moderate upward adjustment suggests Pictet Asset Management's AI signals, combined with its factor exposure methodology, identified strengthening positive signals for the Health Care sector company. The system, continuously assessing fundamentals, momentum, valuation, and sentiment across its developed-international universe, likely prompted this re-allocation for GALD within PQNT's approximately 300 ex-US holdings. Such precise, gradual shifts align with a strategy where AI dynamically informs periodic rebalancing decisions for specific international developed-market stocks.
weight 1.000% → 1.050% (+0.050 pp)
Jul 19·now $211.45
price n/a
PQNT · Weight decrease · 2d
Observing a sequential reduction in GALD's weighting within PQNT suggests GALDERMA GROUP AG experienced a recent downward price trajectory or weakening technical indicators between early and mid-July 2026. Pictet Asset Management's AI-managed PQNT, leveraging AI signals combined with factor exposures like fundamentals, momentum, valuation, and sentiment across its developed-international universe, likely detected a deteriorating risk-return profile for this Health Care stock. Consequently, the fund initiated a periodic rebalance, systematically decreasing GALD's allocation from 1.0800% to 1.0000% over several days in July. This methodical, incremental de-weighting, observed across the 9th, 12th, 15th, and 16th of July, reflects the fund's AI-driven response to its evolving assessment of GALDERMA GROUP AG.
weight 1.030% → 1.000% (-0.030 pp)
Jul 16·now $211.45
price n/a
PQNT · Weight decrease · 2d
Pictet Asset Management's PQNT, integrating AI signals with factor exposures across its broad developed-international portfolio, adjusted its GALD position in response to evolving underlying metrics. Given PQNT's periodic rebalancing cadence for its approximately 300 international developed-market stocks, the observed consecutive weight decreases for GALD suggest the AI-driven assessment of factors like fundamentals, momentum, valuation, or sentiment signaled a reduced allocation. This recalibration is evident in the decrease to 1.0300% by June 28th, indicating a revised contribution for the Health Care sector holding within the fund's ex-US exposure.
weight 1.090% → 1.030% (-0.060 pp)
Jun 28·now $211.45
price n/a
price n/a
PQNT · Weight increase · 2d
GALDERMA GROUP AG experienced a consecutive weight increase in Pictet Asset Management's PQNT ETF, rising from 1.0600% on May 30, 2026, to 1.0900% on May 31, 2026, after an earlier brief decrease to 1.0500% on May 28. This upward adjustment for the Health Care sector stock signals that PQNT's AI-driven methodology, which combines factor exposures like fundamentals, momentum, valuation, and sentiment, identified GALD as an increasingly attractive component within its broad ex-US developed-market universe of approximately 300 stocks. The sequential increase, occurring during a periodic rebalance, suggests the AI models likely converged on a positive outlook for GALD, possibly influenced by recent market activity or improved underlying factor scores that made the company a more compelling holding at its current valuation within PQNT's international developed-market portfolio.
weight 1.050% → 1.090% (+0.040 pp)
May 31·now $211.45
price n/a
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.